BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

934 related articles for article (PubMed ID: 20828590)

  • 1. Targeting podocyte-associated diseases.
    Leeuwis JW; Nguyen TQ; Dendooven A; Kok RJ; Goldschmeding R
    Adv Drug Deliv Rev; 2010 Nov; 62(14):1325-36. PubMed ID: 20828590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of podocytes in glomerular pathobiology.
    Asanuma K; Mundel P
    Clin Exp Nephrol; 2003 Dec; 7(4):255-9. PubMed ID: 14712353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular make-up of the glomerular filtration barrier.
    Patrakka J; Tryggvason K
    Biochem Biophys Res Commun; 2010 May; 396(1):164-9. PubMed ID: 20494132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendrin location in podocytes is associated with disease progression in animal and human glomerulopathy.
    Asanuma K; Akiba-Takagi M; Kodama F; Asao R; Nagai Y; Lydia A; Fukuda H; Tanaka E; Shibata T; Takahara H; Hidaka T; Asanuma E; Kominami E; Ueno T; Tomino Y
    Am J Nephrol; 2011; 33(6):537-49. PubMed ID: 21606645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The podocyte in health and disease: insights from the mouse.
    Michaud JL; Kennedy CR
    Clin Sci (Lond); 2007 Jun; 112(6):325-35. PubMed ID: 17291194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Podocyte injury and glomerular sclerosis].
    Matsusaka T
    Nihon Rinsho; 2004 Oct; 62(10):1805-10. PubMed ID: 15500122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COL4A3/COL4A4 mutations link familial hematuria and focal segmental glomerulosclerosis. glomerular epithelium destruction via basement membrane thinning?
    Voskarides K; Pierides A; Deltas C
    Connect Tissue Res; 2008; 49(3):283-8. PubMed ID: 18661361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of podocyte injury in chronic kidney disease].
    Asanuma K
    Nihon Rinsho Meneki Gakkai Kaishi; 2015; 38(1):26-36. PubMed ID: 25765686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting signaling pathways in glomerular diseases.
    Henique C; Tharaux PL
    Curr Opin Nephrol Hypertens; 2012 Jul; 21(4):417-27. PubMed ID: 22660552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of chronic kidney disease: insights from animal models.
    Zoja C; Abbate M; Remuzzi G
    Curr Opin Nephrol Hypertens; 2006 May; 15(3):250-7. PubMed ID: 16609291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Podocyte dysfunction and proteinuria].
    Vogtländer NP; Rietjens SJ; van der Vlag J; Berden JH
    Ned Tijdschr Geneeskd; 2004 Apr; 148(15):712-8. PubMed ID: 15119204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell biology of the glomerular podocyte.
    Pavenstädt H; Kriz W; Kretzler M
    Physiol Rev; 2003 Jan; 83(1):253-307. PubMed ID: 12506131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of podocyte damage in the pathogenesis of glomerulosclerosis and possible repair mechanisms].
    Ronconi E; Mazzinghi B; Sagrinati C; Angelotti ML; Ballerini L; Parente E; Romagnani P; Lazzeri E; Lasagni L
    G Ital Nefrol; 2009; 26(6):660-9. PubMed ID: 19918748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The spectrum of focal segmental glomerulosclerosis: new insights.
    D'Agati VD
    Curr Opin Nephrol Hypertens; 2008 May; 17(3):271-81. PubMed ID: 18408478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Podocytes are firmly attached to glomerular basement membrane in kidneys with heavy proteinuria.
    Lahdenkari AT; Lounatmaa K; Patrakka J; Holmberg C; Wartiovaara J; Kestilä M; Koskimies O; Jalanko H
    J Am Soc Nephrol; 2004 Oct; 15(10):2611-8. PubMed ID: 15466265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Actin dynamics at focal adhesions: a common endpoint and putative therapeutic target for proteinuric kidney diseases.
    Sever S; Schiffer M
    Kidney Int; 2018 Jun; 93(6):1298-1307. PubMed ID: 29678354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitizing the Slit Diaphragm with TRPC6 ion channels.
    Möller CC; Flesche J; Reiser J
    J Am Soc Nephrol; 2009 May; 20(5):950-3. PubMed ID: 18784209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of nonimmune glomerulopathies.
    Kwoh C; Shannon MB; Miner JH; Shaw A
    Annu Rev Pathol; 2006; 1():349-74. PubMed ID: 18039119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of podocyte phenotype in collapsing glomerulopathies.
    Barisoni L; Kopp JB
    Microsc Res Tech; 2002 May; 57(4):254-62. PubMed ID: 12012394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Podocyte lesions in patients with obesity-related glomerulopathy.
    Chen HM; Liu ZH; Zeng CH; Li SJ; Wang QW; Li LS
    Am J Kidney Dis; 2006 Nov; 48(5):772-9. PubMed ID: 17059996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.